302440 — SK Bioscience Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Market Cap
KR₩3tn
Enterprise Value
KR₩3tn
Revenue
KR₩268bn

Annual balance sheet for SK Bioscience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	208,708	1,645,663	1,475,506	1,268,841	1,156,508
Net Total Accounts Receivable
Net Total Receivables	54,008	48,135	89,661	22,342	188,396
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	333,902	1,837,804	1,783,694	1,382,969	1,576,673
Net Property, Plant And Equipment	189,479	220,983	293,057	315,923	982,607
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	562,232	2,110,123	2,141,931	1,852,439	2,843,596
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	180,639	459,952	380,037	135,620	310,589
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	298,442	508,811	400,229	148,584	1,041,031
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	263,790	1,601,312	1,741,702	1,703,855	1,802,565
Total Liabilities & Shareholders' Equity	562,232	2,110,123	2,141,931	1,852,439	2,843,596
Total Common Shares Outstanding